Direct determination of mitoxantrone and its mono- and dicarboxylic metabolites in plasma and urine by high-performance liquid chromatography.
The simultaneous isolation and determination of mitoxantrone (Novantrone) and its two known metabolites (the mono- and dicarboxylic metabolites) were carried out using a high-performance liquid chromatographic (HPLC) system equipped with an automatic pre-column-switching system that permits drug analysis by direct injection of biological samples. Plasma or urine samples were injected directly on to an enrichment pre-column flushed with methanol-water (5:95, v/v) as the mobile phase. The maximum amount of endogenous water-soluble components was removed from biological samples within 9 min. Drugs specifically adsorbed on the pre-column were back-flushed on to an analytical column (Nucleosil C18, 250 X 4.6 mm I.D.) with 1.6 M ammonium formate buffer (pH 4.0) (2.5% formic acid) containing 20% acetonitrile. Detection was effected at 655 nm. Chromatographic analysis was performed within 12 min. The detection limit of the method was about 4 ng/ml for urine and 10 ng/ml for plasma samples. The precision ranged from 3 to 11% depending on the amount of compound studied. This technique was applied to the monitoring of mitoxantrone in plasma and to the quantification of the unchanged compound and its two metabolites in urine from patients receiving 14 mg/m2 of mitoxantrone by intravenous infusion for 10 min.
Payet
B
B
INSERM-U278, Faculté de Pharmacie, Marseille, France.
Arnoux
P
P
Catalin
J
J
Cano
J P
JP
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007202:Indicators and Reagents; D007262:Infusions, Intravenous; D008942:Mitoxantrone / Q000031:analogs & derivatives* / Q000032:analysis* / Q000097:blood / Q000652:urine
D007202:Indicators and Reagents; C055849:mitoxantrone carboxylic acid; C055847:mitoxantrone dicarboxylic acid; D008942:Mitoxantrone